In advanced progressive CKD, discontinuing RAS inhibitors did not improve eGFR at 3 y

Donald Molony; Andrew Horvit; Dia Waguespack

doi:10.7326/J23-0001

In advanced progressive CKD, discontinuing RAS inhibitors did not improve eGFR at 3 y

Ann Intern Med. 2023 Mar;176(3):JC28. doi: 10.7326/J23-0001. Epub 2023 Mar 7.

Authors

Donald Molony¹, Andrew Horvit¹, Dia Waguespack¹

Affiliation

¹ University of Texas Health Science Center at Houston-McGovern Medical School, Houston, Texas, USA (D.M., A.H., D.W.).

PMID: 36877968
DOI: 10.7326/J23-0001

Abstract

Bhandari S, Mehta S, Khwaja A, et al. Renin-angiotensin system inhibition in advanced chronic kidney disease. N Engl J Med. 2022;387:2021-32. 36326117.

Publication types

Comment

MeSH terms

Angiotensin-Converting Enzyme Inhibitors* / therapeutic use
Humans
Renal Insufficiency, Chronic* / drug therapy
Renin-Angiotensin System

Substances

Angiotensin-Converting Enzyme Inhibitors